TNFSF10 and ovarian clear cell adenocarcinoma: CBX7 is associated with poor prognosis in ovarian clear cell adenocarcinoma [64] by modulating the level of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and inhibiting apoptosis.